1 option
Clinical review report Tenofovir alafenamide (Vemlidy) (Gilead Sciences Canada, Inc.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- Adulthood.
- Hepatitis B.
- Physical Description:
- 1 online resource (1 PDF file (65 pages)) : illustrations
- Other Title:
- Clinical review report Tenofovir alafenamide
- Place of Publication:
- Ottawa, Ontario : Canadian Agency for Drugs and Technologies in Health, 2018.
- Summary:
- The objective of this report was to perform a systematic review of the beneficial and harmful effects of tenofovir alafenamide for the treatment of adults with chronic hepatitis B (CHB) and compensated liver disease.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.